Improving Treatments for Inflammatory Bowel Diseases with Drug-Delivering Nanoparticles

Drug-delivering nanoparticles could improve treatments for inflammatory bowel diseases that affect the quality of life of more than 3 million Americans, Iowa State University researchers say.

Related Keywords

United States ,Iowa State University ,Iowa ,Americans ,Gregory Phillips ,Rizia Bardhan ,Michael Wannemuehler ,Saji Uthaman ,Laura Thomsonapr ,Gut Health ,Drug Administration ,Nanovaccine Institute ,Iowa State ,Enabling Gut ,